Join the Influenza Prophylaxis group to help and get support from people like you.
Influenza Prophylaxis News
Related terms: Flu Prevention
No Elevated Risk for Stroke Seen After COVID-19 Bivalent Vaccine Receipt
WEDNESDAY, March 20, 2024 – For Medicare beneficiaries aged 65 years and older, there is no evidence of elevated stroke risk immediately after vaccination with either brand of the COVID-19 bivalent...
Birth Month Linked to Timing of Influenza Vaccination in Young Children
THURSDAY, Feb. 22, 2024 – For young children, birth month is associated with timing of influenza vaccination, according to a study published online Feb. 21 in The BMJ. Christopher M. Worsham, M.D.,...
Flu Activity Slows Down, But Season Far From Over: CDC
MONDAY, Jan. 15, 2024 – Following weeks of increases in flu activity, the latest U.S. government data shows "a single-week decrease" for the first time in months. But health officials warn that the...
Could Antibody Discovery Lead to Better Flu Vaccines?
FRIDAY, Dec. 29, 2023 – Researchers appear to have discovered a new weapon in the war on a particularly difficult foe. They have identified a previously unrecognized class of antibodies that seem to...
Most U.S. Parents Plan to Vaccinate Kids Against Flu, RSV: Survey
MONDAY, Dec. 18, 2023 – Most parents plan to have their kids vaccinated against influenza and respiratory syncytial virus (RSV), even as COVID-19 vaccine acceptance flags, a new poll finds. Seven in...
Too Few Americans Are Getting Vaccinated for Flu, COVID & RSV, CDC Warns
FRIDAY, Dec. 15, 2023 – Low vaccination rates for the flu, RSV and COVID-19 are putting Americans at higher risk for severe illness and hospitalization this winter, a new government alert warned...
Flu Shots Up for Children in States With Vaccine Mandate
TUESDAY, Oct. 10, 2023 – Children living in states with a vaccine mandate during the 2020 to 2021 influenza season had a higher predicted probability of receiving an influenza vaccine, according to...
In Early Trial, Results Promising for Moderna Combo COVID-Flu Vaccine
THURSDAY, Oct. 5, 2023 – Moderna Inc. announced Wednesday that it has seen positive early results with a new vaccine that would guard against four strains of flu plus COVID-19. In interim findings...
It's Time to Start Preparing Against Flu, RSV & COVID-19
FRIDAY, Sept. 15, 2023 – Kids are back in school and it’s time to think about viruses, for both yourself and them. It could be an early flu season in the United States, if what happened in the Sou...
Teens May Have Missed Vaccinations During COVID-19 Pandemic
MONDAY, Aug. 28, 2023 – Adolescents, especially those born in 2008, may have missed vaccinations during the COVID-19 pandemic, according to research published in the Aug. 25 issue of the U.S....
Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person
South San Francisco, CA – November 23, 2020 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved a...
FDA Approves Fluzone High-Dose Quadrivalent (Influenza Vaccine) for Adults 65 Years of Age and Older
PARIS, Nov. 4, 2019 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone High-Dose Quadrivalent (Influenza Vaccine) for...
FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age
BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ – The U.S. Food and Drug Administration has approved the use of the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) to include children age 6...
GSK Receives FDA Approval for Expanded Indication for Fluarix Quadrivalent (Influenza Vaccine) for Persons 6 Months and Older
Philadelphia, PA, January 11, 2018 – GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research e...
Seqirus Receives FDA Approval of Afluria Quadrivalent (Influenza Vaccine) for People Five Years of Age and Older in the U.S.
Cambridge, Mass — September 14, 2017 – Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in people five years of a...
Ask a question
To post your own question to this support group, sign in or create an account.